Turn Therapeutics Inc. (TTRX) stock
TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.35−0.79 (-7.75%)
Close on Nov 13, 2026Market cap $278.37MP/E –Yield –
Earnings
Turn Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 30, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.21
-$0.07 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Turn Therapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 30, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 9, 2026before the open | – | – | -$0.21 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 12, 2026after the close | – | – | -$0.20 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 11, 2026after the close | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 31, 2026after the close | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 13, 2025before the open | – | – | -$0.07 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Turn Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Turn Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Turn Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Update
- Update
- Results
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Results
See a number that looks wrong?